277 related articles for article (PubMed ID: 22516641)
1. [Iron deficiency and anemia in oncology].
Scotté F; Launay-Vacher V; Ray-Coquard I
Bull Cancer; 2012 May; 99(5):563-70. PubMed ID: 22516641
[TBL] [Abstract][Full Text] [Related]
2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
3. The role of erythropoiesis-stimulating agents in the treatment of anemia.
Fishbane S
Am J Manag Care; 2010 Mar; 16 Suppl Issues():S67-73. PubMed ID: 20297874
[TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
Nowrousian MR; Dunst J; Vaupel P
Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
[TBL] [Abstract][Full Text] [Related]
5. [New treatments of anemia in chronic renal failure].
Fernández Lorente L; Romero R
Med Clin (Barc); 2014 Jul; 143(1):39-42. PubMed ID: 24467877
[No Abstract] [Full Text] [Related]
6. Iron supplementation during treatment with erythropoiesis-stimulating agents for cancer-related anemia.
Schiavetto I; Pedrazzoli P; Basilico V; Siena S
Chemotherapy; 2008; 54(6):417-20. PubMed ID: 18824846
[TBL] [Abstract][Full Text] [Related]
7. Anemia and iron management.
Besarab A
Semin Dial; 2011; 24(5):498-503. PubMed ID: 21906169
[No Abstract] [Full Text] [Related]
8. [Diagnosis and treatment of anemia in heart failure patients].
Santilli G; Tarantini L; Baio P; Senni M
G Ital Cardiol (Rome); 2011 May; 12(5):319-26. PubMed ID: 21593950
[TBL] [Abstract][Full Text] [Related]
9. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
Aapro MS; Link H
Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.
Henry DH; Dahl NV; Auerbach MA
Am J Hematol; 2012 Mar; 87(3):308-10. PubMed ID: 22262486
[TBL] [Abstract][Full Text] [Related]
11. New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony.
Steensma DP
J Support Oncol; 2007; 5(10):471-3. PubMed ID: 18240668
[No Abstract] [Full Text] [Related]
12. [Anemia in patients with cancer].
Kobune M; Kato J; Niitsu Y
Nihon Rinsho; 2008 Mar; 66(3):524-9. PubMed ID: 18330028
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
14. Anemia of critical illness.
Asare K
Pharmacotherapy; 2008 Oct; 28(10):1267-82. PubMed ID: 18823222
[TBL] [Abstract][Full Text] [Related]
15. Anaemia management in cardio renal disease.
Silverberg DS; Wexler D; Iaina A; Schwartz D
J Ren Care; 2010 May; 36 Suppl 1():86-96. PubMed ID: 20586904
[TBL] [Abstract][Full Text] [Related]
16. Anaemia, diabetes and chronic kidney disease: where are we now?
Stevens PE
J Ren Care; 2012 Feb; 38 Suppl 1():67-77. PubMed ID: 22348366
[TBL] [Abstract][Full Text] [Related]
17. Future directions in management of anemia in heart failure.
Agarwal AK; Katz SD
Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
[TBL] [Abstract][Full Text] [Related]
18. Response to "effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia".
Coiffier B
Oncologist; 2005 Oct; 10(9):762-3; author reply 764-5. PubMed ID: 16249359
[No Abstract] [Full Text] [Related]
19. Strategies to optimize the use of erythropoietin and iron therapy in oncology patients.
Ford PA; Mastoris J
Transfusion; 2004 Dec; 44(12 Suppl):15S-25S. PubMed ID: 15585001
[No Abstract] [Full Text] [Related]
20. Committee releases new guidelines on the use of erythropoiesis-stimulating agents.
McBride D
ONS Connect; 2011 Feb; 26(2):19. PubMed ID: 21388023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
